STACEY BERG to TOR Serine-Threonine Kinases
This is a "connection" page, showing publications STACEY BERG has written about TOR Serine-Threonine Kinases.
Connection Strength
0.195
-
Phase II Study of Samotolisib in Children and Young Adults With Tumors Harboring Phosphoinositide 3-Kinase/Mammalian Target of Rapamycin Pathway Alterations: Pediatric MATCH APEC1621D. JCO Precis Oncol. 2024 Sep; 8:e2400258.
Score: 0.195